Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Attribution of Toxicities Due to Radiotherapy and Immuno-Biological Therapies - Registry

NCT04115267 is registered in ClinicalTrials.gov with Centre hospitalier de l'Université de Montréal (CHUM) as lead sponsor.

NCT NCT04115267
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04115267 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Attribution of Toxicities Due to Radiotherapy and Immuno-Biological Therapies - Registry
Lead sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Phase
Observational
Overall status
Recruiting
Start date
September 13, 2019
Completion date
September 30, 2030
Enrollment
3,600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, radiotherapy side effect